Loading...
Initial Testing (Stage 1) of the Phosphatidylinositol 3’ Kinase Inhibitor, SAR245408 (XL147) by the Pediatric Preclinical Testing Program
BACKGROUND: Activation of the PI3 kinase pathway occurs frequently in many adult cancers and is implicated in tumor cell proliferation, survival, and resistance to chemotherapy and radiotherapy. However, less is known regarding the relevance of this pathway in pediatric cancers. Here we have evaluat...
Na minha lista:
| Udgivet i: | Pediatr Blood Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4684943/ https://ncbi.nlm.nih.gov/pubmed/23002019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24301 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|